Position 5-7: Finalization

Nose

Select the specific approach and device combination to identify the exact billable procedure code.

Approach 3

Percutaneous

Device 0

3E09305 Introduction Nose to Other Antineoplastic with Antineoplastic, Percutaneous Approach
3E0930M Introduction Nose to Monoclonal Antibody with Antineoplastic, Percutaneous Approach

Device 2

3E09328 Introduction Nose to Oxazolidinones with Anti-infective, Percutaneous Approach
3E09329 Introduction Nose to Other Anti-infective with Anti-infective, Percutaneous Approach

Device 3

3E0933Z Introduction Nose to No Qualifier with Anti-inflammatory, Percutaneous Approach

Device 4

3E0934Z Introduction Nose to No Qualifier with Serum, Toxoid and Vaccine, Percutaneous Approach

Device B

3E093BZ Introduction Nose to No Qualifier with Anesthetic Agent, Percutaneous Approach

Device G

3E093GC Introduction Nose to Other Substance with Other Therapeutic Substance, Percutaneous Approach

Device H

3E093HZ Introduction Nose to No Qualifier with Radioactive Substance, Percutaneous Approach

Device K

3E093KZ Introduction Nose to No Qualifier with Other Diagnostic Substance, Percutaneous Approach

Device N

3E093NZ Introduction Nose to No Qualifier with Analgesics, Hypnotics, Sedatives, Percutaneous Approach

Device T

3E093TZ Introduction Nose to No Qualifier with Destructive Agent, Percutaneous Approach
Approach 7

Via Natural or Artificial Opening

Device 0

3E09705 Introduction Nose to Other Antineoplastic with Antineoplastic, Via Natural or Artificial Opening Approach
3E0970M Introduction Nose to Monoclonal Antibody with Antineoplastic, Via Natural or Artificial Opening Approach

Device 2

3E09728 Introduction Nose to Oxazolidinones with Anti-infective, Via Natural or Artificial Opening Approach
3E09729 Introduction Nose to Other Anti-infective with Anti-infective, Via Natural or Artificial Opening Approach

Device 3

3E0973Z Introduction Nose to No Qualifier with Anti-inflammatory, Via Natural or Artificial Opening Approach

Device 4

3E0974Z Introduction Nose to No Qualifier with Serum, Toxoid and Vaccine, Via Natural or Artificial Opening Approach

Device B

3E097BZ Introduction Nose to No Qualifier with Anesthetic Agent, Via Natural or Artificial Opening Approach

Device G

3E097GC Introduction Nose to Other Substance with Other Therapeutic Substance, Via Natural or Artificial Opening Approach

Device H

3E097HZ Introduction Nose to No Qualifier with Radioactive Substance, Via Natural or Artificial Opening Approach

Device K

3E097KZ Introduction Nose to No Qualifier with Other Diagnostic Substance, Via Natural or Artificial Opening Approach

Device N

3E097NZ Introduction Nose to No Qualifier with Analgesics, Hypnotics, Sedatives, Via Natural or Artificial Opening Approach

Device T

3E097TZ Introduction Nose to No Qualifier with Destructive Agent, Via Natural or Artificial Opening Approach
Approach X

External

Device 0

3E09X05 Introduction Nose to Other Antineoplastic with Antineoplastic, External Approach
3E09X0M Introduction Nose to Monoclonal Antibody with Antineoplastic, External Approach

Device 2

3E09X28 Introduction Nose to Oxazolidinones with Anti-infective, External Approach
3E09X29 Introduction Nose to Other Anti-infective with Anti-infective, External Approach

Device 3

3E09X3Z Introduction Nose to No Qualifier with Anti-inflammatory, External Approach

Device 4

3E09X4Z Introduction Nose to No Qualifier with Serum, Toxoid and Vaccine, External Approach

Device B

3E09XBZ Introduction Nose to No Qualifier with Anesthetic Agent, External Approach

Device G

3E09XGC Introduction Nose to Other Substance with Other Therapeutic Substance, External Approach

Device H

3E09XHZ Introduction Nose to No Qualifier with Radioactive Substance, External Approach

Device K

3E09XKZ Introduction Nose to No Qualifier with Other Diagnostic Substance, External Approach

Device N

3E09XNZ Introduction Nose to No Qualifier with Analgesics, Hypnotics, Sedatives, External Approach

Device T

3E09XTZ Introduction Nose to No Qualifier with Destructive Agent, External Approach